Pyruvate kinase deficiency, explained for families | CION Cancer Clinics

Pyruvate kinase deficiency is an inherited condition in which red blood cells cannot make enough energy to survive their normal lifespan. They break down early, and the result is a long-lasting anaemia, meaning a low haemoglobin, that ranges from barely noticeable to needing regular blood transfusions.

Why the red cells break down

Pyruvate kinase is an enzyme, a working protein, that red cells use to turn sugar into energy. A red cell has no other way to make energy. Without enough of it, the cell becomes stiff and misshapen, and the spleen removes it from the blood well before its time. Doctors call this early breakdown haemolysis.

How you inherit it

The condition comes from changes in a gene called PKLR. A child is affected only when they receive a changed copy from both parents. Parents who carry one copy are usually well and often have no idea they are carriers. It is more common where relatives marry each other, which is still a pattern in some families across Telangana and Andhra Pradesh.

Treatment aims to keep you well, growing and active, and to prevent the slow damage from iron and gallstones. It cannot be treated away with a tablet, and the plan changes over a lifetime.

Watching and supporting

Mild cases often need only regular check-ups, folic acid to support red cell making, and quick attention during infections. People with this condition often feel better than their haemoglobin suggests, so decisions are based on how you feel and grow, not on one number.

Blood transfusions and iron removal

Some children and adults need transfusions, either now and then or on a schedule. Iron builds up both from transfusions and from the condition itself, so chelation, medicine that removes extra iron, is often needed. Never stop or change it without your haematologist.

Removing the spleen

Taking out the spleen, called splenectomy, can raise the haemoglobin and cut the need for transfusions. It does not suit very young children, and it raises the lifelong risk of serious infection and blood clots. Vaccines are given beforehand.

Newer options

Mitapivat is a tablet that switches on the remaining enzyme. It is approved in some countries for adults, but it tends not to help people whose two gene changes both stop the enzyme being made at all. Bone marrow transplant is kept for rare, severe cases and is done at specialist centres.

This page cannot tell you how severe your own or your child's condition will be. That depends on the exact gene changes, how the body copes, and how things change over the years. Your haematologist builds that picture over several visits, not from one report.

Planning a family

If you or your partner carry the condition, genetic counselling can explain the chance of an affected child and the testing options in a future pregnancy. Women with the condition need closer care in pregnancy, because the anaemia often worsens.

What to bring to your appointment

Bring every blood report, including old ones, the dates of any transfusions, and any scan showing gallstones or the spleen. Bring the family member who helps with decisions. At CION, a haematologist reviews the case, discusses it with a wider team, and coordinates specialist tests or transplant opinions with qualified centres where they are needed.